CGCG clinical practice guidelines for the management of adult diffuse gliomas
CGCG clinical practice guidelines for the management of adult diffuse gliomas
复制标题
CGCG 成人弥漫性胶质瘤治疗临床实践指南。
DOI：
10.1016/j.canlet.2016.01.024
复制
发表时间：
2016-06-01
期刊：
影响因子：
9.7
通讯作者：
Wang, Qixue
中科院分区：
文献类型：
--
作者：
Jiang, Tao;Mao, Ying;Wang, Qixue
中国胶质瘤协作组（CGCG）成人弥漫性胶质瘤指南提供了诊断和治疗程序的建议。该小组涵盖了神经肿瘤学的所有专业领域，即神经外科医生、神经科医生、神经病理学家、神经放射学家、放射和医学肿瘤学家以及临床试验专家。这项任务通过搜索被认为最相关的参考资料并评估其价值，对被认为最相关的成果作出了更明确和更透明的选择。根据牛津循证医学中心的证据等级对从文献中收集的论文的科学证据进行评价和分级，并给出相应的建议。这些建议将为诊断和治疗措施战略提供框架和保证，以减少不必要的治疗和费用引起的并发症。该指南应作为所有参与成人弥漫性胶质瘤患者管理的专业人员的应用程序，也可作为保险公司和其他参与中国癌症治疗费用监管的机构的知识来源。(C)2016作者出版社：Elsevier爱尔兰Ltd.
The Chinese Glioma Cooperative Group (CGCG) Guideline Panel for adult diffuse gliomas provided recommendations for diagnostic and therapeutic procedures. The Panel covered all fields of expertise in neurooncology, i.e. neurosurgeons, neurologists, neuropathologists, neuroradiologists, radiation and medical oncologists and clinical trial experts. The task made clearer and more transparent choices about outcomes considered most relevant through searching the references considered most relevant and evaluating their value. The scientific evidence of papers collected from the literature was evaluated and graded based on the Oxford Centre for Evidence-based Medicine Levels of Evidence and recommendations were given accordingly. The recommendations will provide a framework and assurance for the strategy of diagnostic and therapeutic measures to reduce complications from unnecessary treatment and cost. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also as a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China. (C) 2016 The Authors. Published by Elsevier Ireland Ltd.